QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:AMGN

Amgen (AMGN) Earnings Date, Estimates & Call Transcripts

$221.88
+3.81 (+1.75%)
(As of 06/5/2023 ET)
Compare
Today's Range
$218.47
▼
$223.04
50-Day Range
$214.27
▼
$253.37
52-Week Range
$211.71
▼
$296.67
Volume
2.50 million shs
Average Volume
2.40 million shs
Market Capitalization
$118.56 billion
P/E Ratio
15.08
Dividend Yield
3.84%
Price Target
$250.94
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Aug. 3Estimated
Actual EPS
(Apr. 27)
$3.98 Beat By $0.14
Consensus EPS
(Apr. 27)
$3.84
Last Year's Q2 EPS
(4/27/2022)
$4.25
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AMGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amgen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20236$3.51$4.47$4.01 
Q2 20236$4.51$4.84$4.68 
Q3 20236$4.41$5.14$4.81 
Q4 20236$4.27$4.76$4.44 
FY 202324$16.70$19.21$17.93 
Q1 20243$4.44$4.86$4.61 
Q2 20243$4.85$5.14$5.00 
Q3 20243$4.71$5.23$4.99 
Q4 20242$4.81$4.91$4.86 
FY 202411$18.81$20.14 $19.45

AMGN Earnings Date and Information

Amgen last announced its earnings data on April 27th, 2023. The medical research company reported $3.98 EPS for the quarter, beating analysts' consensus estimates of $3.84 by $0.14. The business earned $6.11 billion during the quarter, compared to analyst estimates of $6.18 billion. Its revenue for the quarter was down 2.1% on a year-over-year basis. Amgen has generated $14.71 earnings per share over the last year ($14.71 diluted earnings per share) and currently has a price-to-earnings ratio of 15.1. Earnings for Amgen are expected to grow by 6.29% in the coming year, from $18.12 to $19.26 per share. Amgen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

Amgen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/3/2023
(Estimated)		        
4/27/2023Q1 2023$3.84$3.98+$0.14$2.68$6.18 billion$6.11 billion    
2/7/2023Q4 22$4.04$4.09+$0.05$5.18$6.77 billion$6.84 billion      
11/3/2022Q3 2022$4.43$4.70+$0.27$5.42$6.56 billion$6.65 billion    
8/4/2022Q2 2022$4.40$4.65+$0.25$6.85$6.53 billion$6.59 billion    
4/27/2022Q1 2022$4.22$4.25+$0.03$5.82$6.09 billion$6.24 billion    
2/7/2022Q4 2021$4.14$4.36+$0.22$5.36$6.87 billion$6.85 billion
11/2/20219/30/2021$4.22$4.67+$0.45$6.03$6.70 billion$6.71 billion    
8/2/20216/30/2021$4.09$4.38+$0.29$7.95$6.43 billion$6.53 billion    
4/26/20213/31/2021$4.05$3.70($0.35)$4.57$6.30 billion$5.90 billion  
2/1/202112/31/2020$3.39$3.81+$0.42$4.86$6.57 billion$6.63 billion  
11/2/20209/30/2020$3.75$4.37+$0.62$5.31$6.38 billion$6.42 billion  
7/28/20206/30/2020$3.81$4.25+$0.44$5.45$6.19 billion$6.21 billion  
4/30/20203/31/2020$3.70$4.17+$0.47$5.27$6.01 billion$6.16 billion  
1/30/2020Q4 2019$3.47$3.64+$0.17$4.43$6.04 billion$6.20 billion  
10/29/2019Q3 2019$3.53$3.66+$0.13$4.05$5.63 billion$5.74 billion  
7/30/2019Q2$3.58$3.97+$0.39$4.37$5.67 billion$5.87 billion  
4/30/20193/31/2019$3.45$3.56+$0.11$3.94$5.55 billion$5.56 billion  
1/29/201912/31/2018$3.26$3.42+$0.16$3.83$5.88 billion$6.23 billion  
10/30/20189/30/2018$3.45$3.69+$0.24$4.52$5.78 billion$5.90 billion  
7/26/2018Q2 2018$3.52$3.83+$0.31$4.18$5.73 billion$6.06 billion  
4/24/2018Q1 2018$3.24$3.47+$0.23$3.69$5.44 billion$5.55 billion  
2/1/2018Q4 2017$3.03$2.89($0.14)$11.67$5.84 billion$5.80 billion  
10/25/2017Q3 2017$3.11$3.27+$0.16$3.78$5.75 billion$5.77 billion
7/25/2017Q2 2017$3.11$3.27+$0.16$3.63$5.67 billion$5.81 billion
4/26/2017Q1 2017$3.00$3.15+$0.15$3.51$5.60 billion$5.46 billion
2/2/2017Q416$2.79$2.89+$0.10$3.19$5.75 billion$5.97 billion  
10/27/2016Q316$2.79$3.02+$0.23$3.36$5.73 billion$5.81 billion  
7/27/2016Q216$2.74$2.84+$0.10$3.21$5.58 billion$5.69 billion  
4/28/2016Q116$2.60$2.90+$0.30$3.30$5.32 billion$5.53 billion  
1/28/2016Q415$2.29$2.61+$0.32$2.85$5.53 billion$5.54 billion  
10/28/2015Q315$2.38$2.72+$0.34$3.00$5.32 billion$5.72 billion  
7/30/2015Q215$2.43$2.57+$0.14$2.99$5.32 billion$5.37 billion  
4/21/2015Q115$2.07$2.48+$0.41$2.85$4.91 billion$5.03 billion  
1/27/2015Q414$2.05$2.16+$0.11$2.64$5.20 billion$5.33 billion  
10/27/2014Q314$2.11$2.30+$0.19$2.99$4.95 billion$5.03 billion  
7/29/2014Q214$2.07$2.37+$0.30$2.73$4.90 billion$5.18 billion  
4/22/2014Q114$1.94$1.87($0.07)$2.32$4.76 billion$4.52 billion  
1/28/2014Q4 2013$1.64$1.81+$0.17$2.29$4.81 billion$5.01 billion  
10/22/2013Q3 2013$1.72$1.93+$0.21$2.07$4.60 billion$4.75 billion  
8/8/2013Q2 2013($0.63)($0.57)+$0.06($0.41)$151.73 million$153.00 million
7/30/2013Q2 2013$1.71$1.88+$0.17$2.11$4.49 billion$4.68 billion  
5/7/2013Q1 2013($0.59)($0.31)+$0.28($0.15)$134.36 million$145.50 million
4/23/2013Q1 2013$1.75$1.95+$0.20$2.02$4.37 billion$4.24 billion  
2/21/2013Q4 2012($0.76)($0.36)+$0.40$113.17 million$127.90 million
1/23/2013Q4 2012$1.42$1.40($0.02)$4.37 billion$4.42 billion  
11/1/2012Q312($0.95)($0.79)+$0.16$80.02 million$89.51 million
10/23/2012$1.47$1.67+$0.20  
8/1/2012($0.69)($0.68)+$0.01
7/26/2012$1.54$1.83+$0.29  
5/2/2012($0.60)($0.68)($0.08)
4/24/2012Q1 2012$1.43$1.59+$0.16$1.70
2/22/2012$1.61$1.50($0.11)
1/26/2012$1.22$1.21($0.01)
11/2/2011($0.27)($0.31)($0.04)  
10/24/2011$1.29$1.40+$0.11
8/3/2011($0.17)($0.43)($0.26)
7/29/2011$1.29$1.37+$0.08
5/4/2011($0.13)($0.23)($0.10)
4/20/2011$1.29$1.34+$0.05
2/23/2011($0.02)($0.28)($0.26)
1/24/2011$1.11$1.17+$0.06  
11/3/2010Q3 2010($0.04)$0.66+$0.70$0.66
10/25/2010Q3 2010$1.26$1.36+$0.10$1.43
8/4/2010Q2 2010($0.03)($0.05)($0.02)$1.45
7/29/2010Q2 2010$1.28$1.34+$0.06$1.43
5/4/2010Q1 2010$0.01($0.10)($0.11)($0.01)
4/21/2010Q1 2010$1.23$1.28+$0.05$1.38
2/23/2010Q4 2009$0.20$0.04($0.16)$0.17
1/25/2010Q4 2009$1.11$1.05($0.06)$1.18
11/3/2009Q3 2009$0.22$0.29+$0.07$0.44
10/21/2009Q3 2009$1.25$1.49+$0.24$1.62
8/4/2009Q2 2009$0.14$0.16+$0.02$0.16
7/27/2009Q2 2009$1.15$1.27+$0.12$1.29
5/6/2009Q1 2009$0.18$0.07($0.11)$0.07
4/23/2009Q1 2009$1.13$1.08($0.05)$1.18
2/23/2009Q4 2008($0.53)($0.53)($0.53)
1/26/2009Q4 2008$1.04$1.04$1.17
11/6/2008Q3 2008$0.01$0.21+$0.20$0.21
10/22/2008Q3 2008$1.06$1.21+$0.15$1.33
8/5/2008Q2 2008$0.10$0.08($0.02)$0.08
7/28/2008Q2 2008$0.98$1.13+$0.15$1.39
5/6/2008Q1 2008($0.07)$0.27+$0.34$0.27
4/24/2008Q1 2008$1.02$1.10+$0.08$1.16
2/19/2008Q4 2007($0.05)($0.21)($0.16)($0.21)
1/24/2008Q4 2007$0.92$0.97+$0.05$1.17












Amgen Earnings - Frequently Asked Questions

When is Amgen's earnings date?

Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on AMGN's earnings history.

Did Amgen beat their earnings estimates last quarter?

In the previous quarter, Amgen (NASDAQ:AMGN) reported $3.98 earnings per share (EPS) to beat the analysts' consensus estimate of $3.84 by $0.14. Learn more on analysts' earnings estimate vs. AMGN's actual earnings.

How can I listen to Amgen's earnings conference call?

The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Amgen's conference call transcript?

The conference call transcript for Amgen's latest earnings report can be read online. Read Transcript

How much revenue does Amgen generate each year?

Amgen (NASDAQ:AMGN) has a recorded annual revenue of $26.32 billion.

How much profit does Amgen generate each year?

Amgen (NASDAQ:AMGN) has a recorded net income of $6.55 billion. AMGN has generated $14.71 earnings per share over the last four quarters.

What is Amgen's price-to-earnings ratio?

Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 15.08 and a forward price-to-earnings ratio of 12.25. The price/earnings-to-growth ratio is 1.72.

What is Amgen's EPS forecast for next year?

Amgen's earnings are expected to grow from $18.12 per share to $19.26 per share in the next year, which is a 6.29% increase.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:AMGN) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -